Logo
V

Veeda Lifesciences

1233 employees

We partner with innovator and generic companies using our high-quality infrastructure and a global network of clinical trial sites, to launch novel therapies and new products for patients worldwide. Building on our strong foundation in global oncology studies, we offer solutions across multiple therapeutic domains, accelerating pipelines through AI and advanced real-world data capabilities.  As an Integrated, Tech-driven & Global CRO we support the development of biotherapeutics and small molecules by blending scientific expertise with advanced technology. With offices in 9 countries and sites spanning across 26 geographies, we offer global reach and local expertise.  Our integrated service model spans the entire drug development lifecycle, offering expertise in:  1. Preclinical studies  2. BA/BE Studies  3. Early Phase clinical trials   4. Late-phase clinical trials  5. Bioanalytical services  6. Biopharma solutions

Investor insights

Funding rounds participated in

$16M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Research Services

Sectors

Research Services

Date founded

2004

Funding rounds raised

Total raised

$16M

from 2 investors over 1 rounds

V

Veeda Lifesciences raised $16M on July 24, 2021

Investors: Sabre Partners and + 4 Other investors

FAQ